Remdesivir Shows Promise as Coronavirus Treatment, Fauci Says

“This is too important to be handled in such a sloppy fashion,” Dr. Nissen said.

Dr. Michele Barry, global health expert at Stanford University, said she had faith in Dr. Fauci’s assessment. Still, she added, “It is unusual to call a drug the ‘standard of care’ until peer review of data and publication, and before studies have shown benefit in mortality.”

Article source: https://www.nytimes.com/2020/04/29/health/gilead-remdesivir-coronavirus.html